Not Found |
Major: 5639N
Catalog Year: 2023-2024
Effective Term: 2014 Spring
Last Admit Term: 2016 Summer
Award: CCL Total Credits: 16 CIP Code: 51.0719 |
Primary College:
Initiating College: Gateway Community College
Program Availability: Not Found
Program Availability: College-Specific
Field of Interest: Not Found
Instructional Council: Applied Technology (57) GPA: 2.00 |
SOC Code: 29-2010
|
Program Prerequisites: None
|
|||||||||||
Required Courses | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
+ CRA290 Introduction to Clinical Research Associate 3 | Credits: 16 |
Restricted Electives | |||
---|---|---|---|
| Credits: |
General Electives | |||
---|---|---|---|
| Credits: |
Program Competencies | |||
---|---|---|---|
1. Prepare a monitoring plan based on a study timeline. (CRA290, CRA291)
2. Audit a subject chart for protocol/regulatory compliance. (CRA290, CRA291) 3. Develop a Clinical Research Associate tool chest to assist in monitoring. (CRA290, CRA291) 4. Design a study and site recruitment strategy. (CRA291) 5. Utilize electronic systems and external resources to provide relevance to everyday functions of the CRA. (CRA291) 6. Present a CRA to Site training modules for the following; Site Initiation Visit, Routine Monitoring and Audit Preparation. (CRA291) 7. Describe potential conflicts with sites and sponsors and create a resolution plan. (CRA291, CRA295) 8. Discuss the key personnel in the study design process. (CRA293) 9. Create a device study plan based on a study timeline. (CRA293) 10. Compare and contrast the study design role of the CRA across therapeutic disciplines. (CRA290, CRA293) 11. Design a study plan timeline for a standard study protocol. (CRA290, CRA293) 12. Describe the significance of the components of an Investigative New Drug (IND) application. (CRA295) 13. Develop a standard regulatory binder to be utilized at a site and sponsor level. (CRA295) 14. Compare and contrast the regulatory differences from the site versus the sponsor perspective. (CRA295) 15. Design regulatory compliant drug and device accountability logs from a site and sponsor perspective. (CRA297) 16. Create a packaging design based upon a study protocol. (CRA297) 17. Compare and contrast the CRA role in drug versus device industry. (CRA297) 18. Prepare career plan for obtaining initial CRA position and career advancement. (CRA290) 19. Apply Good Clinical Practice (GCP) guidelines and regulatory processes to the CRA role. (CRA290, CRA291, CRA293, CRA295, CRA297) | |||
+ indicates course has prerequisites and/or corequisites.
++ indicates that any suffixed course may be selected. MCCCD Governing Board Approval Date: October 22, 2013 |